{"nct_id":"NCT01830543","title":"A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention","status":"COMPLETED","status_verified_date":"2017-08","start_date":"2013-05-10","start_date_type":"ACTUAL","primary_completion_date":"2016-07-28","primary_completion_date_type":"ACTUAL","completion_date":"2016-07-28","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}